Ipsen Late-Breaking Data Raises Ambitions In PBC
Nov 5 (Reuters) - Ipsen SA IPN.PA:
LATE-BREAKING DATA RAISES AMBITIONS IN PBC WITH MORE THAN 85% OF PATIENTS ON TREATMENT ACHIEVING ALP NORMALIZATION
AT WEEK 52, 85.3% OF PATIENTS RECEIVING IQIRVO® ACHIEVED NORMALIZATION OF ALP COMPARED WITH 23.3% RECEIVING PLACEBO
Further company coverage: IPN.PA